Vedanta Biosciences enrolls first patient in VE416 phase 1b/2 food allergy clinical study

Vedanta Biosciences announced the first patient has been enrolled in the Phase 1b/2 clinical study of VE416 in adults and adolescents with a history of peanut allergy.